TNF and benign prostatic hyperplasia: The release of TNF-α reached a maximum in BPH-treated ADSCs, as compared to control untreated cells (Panel A), while for IL-6 the higher concentrations were measured in in cells exposed to PL (Panel B), as compared to untreated control ADSCs.